Synthesis, Crystal Structure and Biological Evaluation of 4, 5, 6, 7-tetrahydropravastatin as HMG-CoA Reductase Inhibitor

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|8|9|884-888

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.8, Iss.9, 2011-11, pp. : 884-888

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthesis and Biological Evaluation of Atorvastatin Derivatives as Novel HMG-CoA Reductase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 9, 2013-01 ,pp. : 817-822

Bentham Science Publishers

Access to resources Recommend Favorite

EFFECT OF THE NEW HMG-CoA REDUCTASE INHIBITOR CERIVASTATIN (BAY W 6228) ON MIGRATION, PROLIFERATION AND CHOLESTEROL SYNTHESIS IN ARTERIAL MYOCYTES

By Corsini A.   Arnaboldi L.   Raiteri M.   Quarato P.   Faggiotto A.   Paoletti R.   Fumagalli R.  

Pharmacological Research, Vol. 33, Iss. 1, 1996-01 ,pp. : 55-61

Academic Press

Access to resources Recommend Favorite

Pluripotential Mechanisms of Cardioprotection with HMG-CoA Reductase Inhibitor Therapy

By Rosenson R.S.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 6, 2001-06 ,pp. : 411-420

Adis International

Access to resources Recommend Favorite

NK-104: a novel synthetic HMG-CoA reductase inhibitor

By Kajinami K.   Mabuchi H.   Saito Y.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2653-2661

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of HMG-CoA Reductase Inhibitors for Multiple Sclerosis: Opportunities and Obstacles

By Neuhaus Oliver  

CNS Drugs, Vol. 19, Iss. 10, 2005-01 ,pp. : 833-841

Adis International

Access to resources Recommend Favorite